| Original language | English (US) |
|---|---|
| Pages (from-to) | 311 |
| Number of pages | 1 |
| Journal | Nature Reviews Endocrinology |
| Volume | 20 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2024 |
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology
Reply to ‘The shift of therapeutic strategy for prolactinomas: surgery as the first-line option’
Stephan Petersenn, Maria Fleseriu, Shlomo Melmed
Research output: Contribution to journal › Letter › peer-review